UncategorizedEXCLUSIVE: Weight-Loss Market Experts Scoop Up Novo Nordisk Stock After Worst Drop Since 2002 Following Drug Trial Miss 3 days ago01 mins Novo Nordisk’s stock plunges 20% after underwhelming weight-loss trial results for its obesity drug. Analysts say market overreacted. read more Post navigation Previous: Why Molecular Templates (MTEM) Stock Is Down 60%Next: Nike Stock Turnaround Path Clear, Analyst Says: ‘Getting Back To Winning Takes Time’ Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
‘A Lack Of A Santa Claus Rally Would Be Concerning,’ Says Analyst As S&P 500 Breadth Hits Lowest Since Jimmy Carter Era 2 hours ago 0
Tesla Deliveries At Risk If $7,500 EV Tax Credit Ends, Researcher Warns Despite CEO Elon Musk Claiming Otherwise 2 hours ago 0
Google Entered ‘Code Red’ After ChatGPT Release, But Gemini 2.0 And Quantum Chip Give Investors ‘Renewed Confidence,’ Says This Portfolio Manager 2 hours ago 0
Starbucks Strike Expands To More US Cities As Wage Negotiations Stall During Busy Holiday Season 2 hours ago 0